08
Mar
2023
12:00
GMT
20:00
SGT
13:00
CET
Webinar
Nebivolol: No Limb Pain?
-
Views:
6979
-
Likes:
22
Overview
Beta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the newer generation of beta-blockers and greater cardio-selectivity. One of the challenges all clinicians face is to manage the choice of numerous beta-blockers and in particular translating the evidence base to real-world practice.
This webinar will provide an overview of the evidence of beta-blockers, and present some key differences between the agents. The webinar will also discuss, through the use of cases, the management of patients who are often excluded from clinical trials, in particular the elderly.
This live webinar is EBAC accredited. 1 CME credit will be granted upon confirmation of successful attendance.
This is an independent activity run by the International Society of Cardiovascular Pharmacotherapy (ISCP) and co-produced in collaboration with Radcliffe Cardiology.
Faculty:
Sang Hong Baek
Bernard Man Yung Cheung
Krzysztof Filipiak
Ganchimeg Ulziisaikhan
Sotiris Antoniou
This webinar is supported by
Agenda
Key Learning Objectives
- To describe the evidence base of beta-blockers in cardiovascular disease including heart failure with particular reference to nebivolol
- List out the key differences of beta-blockers with regard to patient population in clinical trials and characteristics of the various agents
- To analyse special and regional issues that impact the use of this drug
- To apply evidence-based recommendations to two real world cases
Target Audience
- Cardiovascular team members - doctors, nurses, pharmacists
- Family physicians
- Internists
- Healthcare students and trainees
- Cardiovascular pharmacotherapy researchers
Faculty Biographies
Sang Hong Baek
Professor Sang Hong Baek, MD, PhD, FACC, FESC, is an Emeritus Professor at The Catholic University of Korea and the President of the International Society of Cardiovascular Pharmacotherapy (2023).
Bernard Man Yung Cheung
Bernard Man Yung Cheung is a Professor in Cardiovascular Therapeutics and heads the Division of Clinical Pharmacology and Therapeutics in the Department of Medicine at the University of Hong Kong's School of Clinical Medicine.
Krzysztof Filipiak
Specialist in: cardiology, internal medicine, arterial hypertension, clinical pharmacology (4 certified specializations).
Ganchimeg Ulziisaikhan
Dr Ganchimeg Ulziisaikhan is a Cardiologist at the National Cardiovascular Center of the Third State Central Hospital in Mongolia and an active member of the Mongolian Society of Cardiologists.
Sotiris Antoniou
Mr Sotiris Antoniou is Consultant Pharmacist at Barts Heart Centre, part of Barts Health NHS Trust.